{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T18:18:30Z","timestamp":1788459510039,"version":"build-2803163510"},"reference-count":91,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pituitary"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s11102-026-01743-0","type":"journal-article","created":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T13:24:45Z","timestamp":1786109085000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Hypothalamic syndrome and acquired hypothalamic obesity: from fragmented care to integrated multidisciplinary management"],"prefix":"10.1007","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8837-4343","authenticated-orcid":false,"given":"Betina","family":"Biagetti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Ramon-Krauel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Jos\u00e9 L\u00f3pez","family":"G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Breton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Lamas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Assumpta","family":"Caix\u00e0s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"PitaGuti\u00e9rrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Dolores Ollero","family":"Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Lecube","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Cristina","family":"Azcona-Sanjulian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Aulinas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esteban Cordero","family":"Asanza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia Monsalve","family":"Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina Diaz","family":"Marsa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5729-9926","authenticated-orcid":false,"given":"Mar\u00eda D.","family":"Ballesteros-Pomar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,7]]},"reference":[{"key":"1743_CR1","doi-asserted-by":"publisher","DOI":"10.1111\/dom.70725","author":"HM van Santen","year":"2026","unstructured":"van Santen HM, Shoemaker AH, Dattani MT et al (2026) Defining acquired hypothalamic obesity: an expert call for unified diagnosis and therapeutic action. Diabetes Obes Metab. https:\/\/doi.org\/10.1111\/dom.70725","journal-title":"Diabetes Obes Metab"},{"key":"1743_CR2","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S2213-8587(24)00283-3","volume":"13","author":"J Argente","year":"2025","unstructured":"Argente J, Farooqi IS, Chowen JA et al (2025) Hypothalamic obesity: from basic mechanisms to clinical perspectives. Lancet Diabetes Endocrinol 13:57\u201368. https:\/\/doi.org\/10.1016\/S2213-8587(24)00283-3","journal-title":"Lancet Diabetes Endocrinol"},{"key":"1743_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-85262-1","volume":"15","author":"HL M\u00fcller","year":"2025","unstructured":"M\u00fcller HL, Witte J, Surmann B et al (2025) Treatment of patients with tumor\/treatment-related hypothalamic obesity in the first two years following surgical treatment or radiotherapy. Sci Rep 15:2118. https:\/\/doi.org\/10.1038\/s41598-025-85262-1","journal-title":"Sci Rep"},{"key":"1743_CR4","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1093\/neuonc\/nov044","volume":"17","author":"AS Sterkenburg","year":"2015","unstructured":"Sterkenburg AS, Hoffmann A, Gebhardt U et al (2015) Survival, hypothalamic obesity, and neuropsychological\/psychosocial status after childhood-onset craniopharyngioma: newly reported long-term outcomes. Neuro Oncol 17:1029\u20131038. https:\/\/doi.org\/10.1093\/neuonc\/nov044","journal-title":"Neuro Oncol"},{"key":"1743_CR5","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s00381-019-04161-9","volume":"36","author":"ET Hidalgo","year":"2020","unstructured":"Hidalgo ET, Orillac C, Kvint S et al (2020) Quality of life, hypothalamic obesity, and sexual function in adulthood two decades after primary gross-total resection for childhood craniopharyngioma. Childs Nerv Syst 36:281\u2013289. https:\/\/doi.org\/10.1007\/s00381-019-04161-9","journal-title":"Childs Nerv Syst"},{"key":"1743_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.876770","volume":"13","author":"M Craven","year":"2022","unstructured":"Craven M, Crowley JH, Chiang L et al (2022) A survey of patient-relevant outcomes in pediatric craniopharyngioma: focus on hypothalamic obesity. Front Endocrinol (Lausanne) 13:876770. https:\/\/doi.org\/10.3389\/fendo.2022.876770","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1743_CR7","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1007\/s10198-025-01786-3","volume":"26","author":"J Witte","year":"2025","unstructured":"Witte J, Touchot N, Surmann B et al (2025) Economics of hypothalamic obesity in patients with craniopharyngioma and other rare sellar\/suprasellar tumors. Eur J Health Econ 26:1557\u20131567. https:\/\/doi.org\/10.1007\/s10198-025-01786-3","journal-title":"Eur J Health Econ"},{"key":"1743_CR8","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1111\/j.1467-789X.2010.00727.x","volume":"11","author":"I Hochberg","year":"2010","unstructured":"Hochberg I, Hochberg Z (2010) Expanding the definition of hypothalamic obesity. Obes Rev 11:709\u2013721. https:\/\/doi.org\/10.1111\/j.1467-789X.2010.00727.x","journal-title":"Obes Rev"},{"key":"1743_CR9","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1210\/er.2018-00017","volume":"40","author":"L van Iersel","year":"2019","unstructured":"van Iersel L, Brokke KE, Adan RAH et al (2019) Pathophysiology and individualized treatment of hypothalamic obesity following craniopharyngioma and other suprasellar tumors: a systematic review. Endocr Rev 40:193\u2013235. https:\/\/doi.org\/10.1210\/er.2018-00017","journal-title":"Endocr Rev"},{"key":"1743_CR10","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1159\/000543544","volume":"99","author":"HM van Santen","year":"2026","unstructured":"van Santen HM (2026) The central control of energy metabolism: hypothalamic obesity is not one disease. Horm Res Paediatr 99:175\u2013184. https:\/\/doi.org\/10.1159\/000543544","journal-title":"Horm Res Paediatr"},{"key":"1743_CR11","doi-asserted-by":"publisher","first-page":"e59","DOI":"10.1016\/j.wneu.2018.06.121","volume":"118","author":"W Ni","year":"2018","unstructured":"Ni W, Shi X (2018) Interventions for the Treatment of Craniopharyngioma-Related Hypothalamic Obesity: A Systematic Review. World Neurosurg 118:e59\u2013e71. https:\/\/doi.org\/10.1016\/j.wneu.2018.06.121","journal-title":"World Neurosurg"},{"key":"1743_CR12","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.1016\/j.clnu.2024.05.028","volume":"43","author":"IMaA Van Roessel","year":"2024","unstructured":"Van Roessel IMaA, Van Den Brink M, Dekker J et al (2024) Feasibility, safety, and efficacy of dietary or lifestyle interventions for hypothalamic obesity: A systematic review. Clin Nutr 43:1798\u20131811. https:\/\/doi.org\/10.1016\/j.clnu.2024.05.028","journal-title":"Clin Nutr"},{"key":"1743_CR13","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-025-02280-z","author":"CL Roth","year":"2026","unstructured":"Roth CL, Doelman-Oldenburger NJ, van Santen HM (2026) Current and future pharmacological interventions for acquired hypothalamic obesity. Drugs. https:\/\/doi.org\/10.1007\/s40265-025-02280-z","journal-title":"Drugs"},{"key":"1743_CR14","doi-asserted-by":"publisher","first-page":"e240493","DOI":"10.1530\/EC-24-0493","volume":"13","author":"M He","year":"2024","unstructured":"He M, Xu H, Ying Z et al (2024) Effectiveness of bariatric surgery on acquired hypothalamic obesity: a systematic review and meta-analysis. Endocr Connect 13:e240493. https:\/\/doi.org\/10.1530\/EC-24-0493","journal-title":"Endocr Connect"},{"key":"1743_CR15","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s11154-025-09998-x","volume":"27","author":"A Goday","year":"2026","unstructured":"Goday A, P\u00e9rez G, Fern\u00e1ndez A et al (2026) Bridging the gap: recommendations to accomplish transition from pediatric to adult care in adolescents living with obesity. Rev Endocr Metab Disord 27:91\u2013107. https:\/\/doi.org\/10.1007\/s11154-025-09998-x","journal-title":"Rev Endocr Metab Disord"},{"key":"1743_CR16","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1159\/000548535","volume":"19","author":"E Guillon","year":"2026","unstructured":"Guillon E, Dubern B, Cl\u00e9ment K, Poitou C (2026) Multidimensional Characterisation of Eating Behaviour in Genetic Obesity: A Systematic Review. Obes Facts 19:164\u2013192. https:\/\/doi.org\/10.1159\/000548535","journal-title":"Obes Facts"},{"key":"1743_CR17","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/0149-7634(82)90056-2","volume":"6","author":"BM King","year":"1982","unstructured":"King BM, Frohman LA (1982) The role of vagally-medicated hyperinsulinemia in hypothalamic obesity. Neurosci Biobehav Rev 6:205\u2013214. https:\/\/doi.org\/10.1016\/0149-7634(82)90056-2","journal-title":"Neurosci Biobehav Rev"},{"key":"1743_CR18","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1007\/s00431-008-0876-x","volume":"168","author":"T Guran","year":"2009","unstructured":"Guran T, Turan S, Bereket A et al (2009) The role of leptin, soluble leptin receptor, resistin, and insulin secretory dynamics in the pathogenesis of hypothalamic obesity in children. Eur J Pediatr 168:1043\u20131048. https:\/\/doi.org\/10.1007\/s00431-008-0876-x","journal-title":"Eur J Pediatr"},{"key":"1743_CR19","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1055\/s-2004-832339","volume":"216","author":"HL M\u00fcller","year":"2004","unstructured":"M\u00fcller HL, Gebhardt U, Etavard-Gorris N et al (2004) Prognosis and sequela in patients with childhood craniopharyngioma -- results of HIT-ENDO and update on KRANIOPHARYNGEOM 2000. Klin Padiatr 216:343\u2013348. https:\/\/doi.org\/10.1055\/s-2004-832339","journal-title":"Klin Padiatr"},{"key":"1743_CR20","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3171\/ped.2007.106.1.3","volume":"106","author":"S Puget","year":"2007","unstructured":"Puget S, Garnett M, Wray A et al (2007) Pediatric craniopharyngiomas: classification and treatment according to the degree of hypothalamic involvement. J Neurosurgery: Pediatr 106:3\u201312. https:\/\/doi.org\/10.3171\/ped.2007.106.1.3","journal-title":"J Neurosurgery: Pediatr"},{"key":"1743_CR21","doi-asserted-by":"publisher","DOI":"10.3171\/2010.1.FOCUS09303","volume":"28","author":"JJ Van Gompel","year":"2010","unstructured":"Van Gompel JJ, Nippoldt TB, Higgins DM, Meyer FB (2010) Magnetic resonance imaging-graded hypothalamic compression in surgically treated adult craniopharyngiomas determining postoperative obesity. Neurosurg Focus 28:E3. https:\/\/doi.org\/10.3171\/2010.1.FOCUS09303","journal-title":"Neurosurg Focus"},{"key":"1743_CR22","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1007\/s12020-015-0683-x","volume":"51","author":"P Mortini","year":"2016","unstructured":"Mortini P, Gagliardi F, Bailo M et al (2016) Magnetic resonance imaging as predictor of functional outcome in craniopharyngiomas. Endocrine 51:148\u2013162. https:\/\/doi.org\/10.1007\/s12020-015-0683-x","journal-title":"Endocrine"},{"key":"1743_CR23","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1530\/EJE-11-0158","volume":"165","author":"HL M\u00fcller","year":"2011","unstructured":"M\u00fcller HL, Gebhardt U, Teske C et al (2011) Post-operative hypothalamic lesions and obesity in childhood craniopharyngioma: results of the multinational prospective trial KRANIOPHARYNGEOM 2000 after 3-year follow-up. Eur J Endocrinol 165:17\u201324. https:\/\/doi.org\/10.1530\/EJE-11-0158","journal-title":"Eur J Endocrinol"},{"key":"1743_CR24","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s11060-013-1128-0","volume":"113","author":"SW Park","year":"2013","unstructured":"Park SW, Jung HW, Lee YA et al (2013) Tumor origin and growth pattern at diagnosis and surgical hypothalamic damage predict obesity in pediatric craniopharyngioma. J Neurooncol 113:417\u2013424. https:\/\/doi.org\/10.1007\/s11060-013-1128-0","journal-title":"J Neurooncol"},{"key":"1743_CR25","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1507\/endocrj.EJ25-0408","volume":"73","author":"HL M\u00fcller","year":"2026","unstructured":"M\u00fcller HL, Tanaka T, Hasegawa T et al (2026) Diagnostic criteria for acquired hypothalamic obesity - international expert guidance document. Endocr J 73:341\u2013353. https:\/\/doi.org\/10.1507\/endocrj.EJ25-0408","journal-title":"Endocr J"},{"key":"1743_CR26","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1016\/j.eprac.2025.07.017","volume":"31","author":"K Nadolsky","year":"2025","unstructured":"Nadolsky K, Garvey WT, Agarwal M et al (2025) American Association of Clinical Endocrinology Consensus Statement: Algorithm for the Evaluation and Treatment of Adults with Obesity\/Adiposity-Based Chronic Disease \u2013 2025 Update. Endocr Pract 31:1351\u20131394. https:\/\/doi.org\/10.1016\/j.eprac.2025.07.017","journal-title":"Endocr Pract"},{"key":"1743_CR27","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/S2213-8587(24)00316-4","volume":"13","author":"F Rubino","year":"2025","unstructured":"Rubino F, Cummings DE, Eckel RH et al (2025) Definition and diagnostic criteria of clinical obesity. Lancet Diabetes Endocrinol 13:221\u2013262. https:\/\/doi.org\/10.1016\/S2213-8587(24)00316-4","journal-title":"Lancet Diabetes Endocrinol"},{"key":"1743_CR28","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.1038\/s41591-024-03095-3","volume":"30","author":"L Busetto","year":"2024","unstructured":"Busetto L, Dicker D, Fr\u00fchbeck G et al (2024) A new framework for the diagnosis, staging and management of obesity in adults. Nat Med 30:2395\u20132399. https:\/\/doi.org\/10.1038\/s41591-024-03095-3","journal-title":"Nat Med"},{"key":"1743_CR29","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1210\/jc.2014-3525","volume":"100","author":"DS Olsson","year":"2015","unstructured":"Olsson DS, Andersson E, Bryngelsson I-L et al (2015) Excess mortality and morbidity in patients with craniopharyngioma, especially in patients with childhood onset: a population-based study in Sweden. J Clin Endocrinol Metab 100:467\u2013474. https:\/\/doi.org\/10.1210\/jc.2014-3525","journal-title":"J Clin Endocrinol Metab"},{"key":"1743_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1161116","volume":"14","author":"F Palmas","year":"2023","unstructured":"Palmas F, Ciudin A, Guerra R et al (2023) Comparison of computed tomography and dual-energy X-ray absorptiometry in the evaluation of body composition in patients with obesity. Front Endocrinol (Lausanne) 14:1161116. https:\/\/doi.org\/10.3389\/fendo.2023.1161116","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1743_CR31","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1007\/s11154-025-09941-0","volume":"26","author":"FT Vieira","year":"2025","unstructured":"Vieira FT, Cai Y, Gonzalez MC et al (2025) Poor muscle quality: A hidden and detrimental health condition in obesity. Rev Endocr Metab Disord 26:723\u2013744. https:\/\/doi.org\/10.1007\/s11154-025-09941-0","journal-title":"Rev Endocr Metab Disord"},{"key":"1743_CR32","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1038\/oby.2009.491","volume":"18","author":"N Rakhshani","year":"2010","unstructured":"Rakhshani N, Jeffery AS, Schulte F et al (2010) Evaluation of a comprehensive care clinic model for children with brain tumor and risk for hypothalamic obesity. Obes (Silver Spring) 18:1768\u20131774. https:\/\/doi.org\/10.1038\/oby.2009.491","journal-title":"Obes (Silver Spring)"},{"key":"1743_CR33","doi-asserted-by":"publisher","first-page":"e803","DOI":"10.1016\/j.wneu.2019.06.037","volume":"129","author":"C Apra","year":"2019","unstructured":"Apra C, Enachescu C, Lapras V et al (2019) Is gross total resection reasonable in adults with craniopharyngiomas with hypothalamic involvement? World Neurosurg 129:e803\u2013e811. https:\/\/doi.org\/10.1016\/j.wneu.2019.06.037","journal-title":"World Neurosurg"},{"key":"1743_CR34","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.3171\/2023.3.JNS222607","volume":"139","author":"EJ Bobeff","year":"2023","unstructured":"Bobeff EJ, Mathios D, Mistry AA et al (2023) Predictors of extent of resection and recurrence following endoscopic endonasal resection of craniopharyngioma. J Neurosurg 139:1235\u20131246. https:\/\/doi.org\/10.3171\/2023.3.JNS222607","journal-title":"J Neurosurg"},{"key":"1743_CR35","doi-asserted-by":"publisher","first-page":"e852","DOI":"10.1016\/j.wneu.2024.04.177","volume":"187","author":"SJ Poiset","year":"2024","unstructured":"Poiset SJ, Song A, In Yoon H et al (2024) Long-term outcomes of surgery and radiation treatment for adult patients with craniopharyngioma. World Neurosurg 187:e852\u2013e859. https:\/\/doi.org\/10.1016\/j.wneu.2024.04.177","journal-title":"World Neurosurg"},{"key":"1743_CR36","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/nrendo.2016.217","volume":"13","author":"HL M\u00fcller","year":"2017","unstructured":"M\u00fcller HL, Merchant TE, Puget S, Martinez-Barbera J-P (2017) New outlook on the diagnosis, treatment and follow-up of childhood-onset craniopharyngioma. Nat Rev Endocrinol 13:299\u2013312. https:\/\/doi.org\/10.1038\/nrendo.2016.217","journal-title":"Nat Rev Endocrinol"},{"key":"1743_CR37","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.jss.2018.01.029","volume":"226","author":"G Wang","year":"2018","unstructured":"Wang G, Zhang X, Feng M, Guo F (2018) Comparing survival outcomes of gross total resection and subtotal resection with radiotherapy for craniopharyngioma: a meta-analysis. J Surg Res 226:131\u2013139. https:\/\/doi.org\/10.1016\/j.jss.2018.01.029","journal-title":"J Surg Res"},{"key":"1743_CR38","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s11060-025-04987-1","volume":"173","author":"HL M\u00fcller","year":"2025","unstructured":"M\u00fcller HL (2025) Long-term quality of life and hypothalamic dysfunction after craniopharyngioma. J Neurooncol 173:233\u2013244. https:\/\/doi.org\/10.1007\/s11060-025-04987-1","journal-title":"J Neurooncol"},{"key":"1743_CR39","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1056\/NEJMoa2213329","volume":"389","author":"PK Brastianos","year":"2023","unstructured":"Brastianos PK, Twohy E, Geyer S et al (2023) BRAF-MEK inhibition in newly diagnosed papillary craniopharyngiomas. N Engl J Med 389:118\u2013126. https:\/\/doi.org\/10.1056\/NEJMoa2213329","journal-title":"N Engl J Med"},{"key":"1743_CR40","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/s11154-020-09564-7","volume":"21","author":"P Mortini","year":"2020","unstructured":"Mortini P, Nocera G, Roncelli F et al (2020) The optimal numerosity of the referral population of pituitary tumors centers of excellence (PTCOE): a surgical perspective. Rev Endocr Metab Disord 21:527\u2013536. https:\/\/doi.org\/10.1007\/s11154-020-09564-7","journal-title":"Rev Endocr Metab Disord"},{"key":"1743_CR41","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1007\/s11102-023-01345-0","volume":"26","author":"A Giustina","year":"2023","unstructured":"Giustina A, Uygur MM, Frara S et al (2023) Pilot study to define criteria for Pituitary Tumors Centers of Excellence (PTCOE): results of an audit of leading international centers. Pituitary 26:583\u2013596. https:\/\/doi.org\/10.1007\/s11102-023-01345-0","journal-title":"Pituitary"},{"key":"1743_CR42","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1210\/endrev\/bnaf025","volume":"46","author":"HM van Santen","year":"2025","unstructured":"van Santen HM, M\u00fcller HL (2025) Management of acquired hypothalamic dysfunction and the hypothalamic syndrome; it is more than obesity. Endocr Rev 46:891\u2013907. https:\/\/doi.org\/10.1210\/endrev\/bnaf025","journal-title":"Endocr Rev"},{"key":"1743_CR43","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.3390\/jcm4091774","volume":"4","author":"CL Roth","year":"2015","unstructured":"Roth CL (2015) Hypothalamic Obesity in Craniopharyngioma Patients: Disturbed Energy Homeostasis Related to Extent of Hypothalamic Damage and Its Implication for Obesity Intervention. J Clin Med 4:1774\u20131797. https:\/\/doi.org\/10.3390\/jcm4091774","journal-title":"J Clin Med"},{"key":"1743_CR44","doi-asserted-by":"publisher","DOI":"10.1093\/ejendo\/lvad009","author":"HM van Santen","year":"2023","unstructured":"van Santen HM, van Schaik J, van Roessel IMAA et al (2023) Diagnostic criteria for the hypothalamic syndrome in childhood. Eur J Endocrinol. https:\/\/doi.org\/10.1093\/ejendo\/lvad009","journal-title":"Eur J Endocrinol"},{"key":"1743_CR45","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s11060-018-2765-0","volume":"138","author":"GH Seo","year":"2018","unstructured":"Seo GH, Choi J-H, Kim Y-M et al (2018) Long-term endocrine effects and trends in body mass index changes in patients with childhood-onset brain tumors. J Neurooncol 138:55\u201362. https:\/\/doi.org\/10.1007\/s11060-018-2765-0","journal-title":"J Neurooncol"},{"key":"1743_CR46","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1210\/endrev\/bnaf008","volume":"46","author":"A Aulinas","year":"2025","unstructured":"Aulinas A, Lawson EA (2025) The Oxytocin System and Implications for Oxytocin Deficiency in Hypothalamic-Pituitary Disease. Endocr Rev 46:518\u2013548. https:\/\/doi.org\/10.1210\/endrev\/bnaf008","journal-title":"Endocr Rev"},{"key":"1743_CR47","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1210\/clinem\/dgaf651","volume":"111","author":"C Atila","year":"2026","unstructured":"Atila C, Refardt J, Christ-Crain M (2026) Arginine Vasopressin Deficiency and Oxytocin Deficiency in the Endocrine Clinic. J Clin Endocrinol Metab 111:922\u2013937. https:\/\/doi.org\/10.1210\/clinem\/dgaf651","journal-title":"J Clin Endocrinol Metab"},{"key":"1743_CR48","doi-asserted-by":"publisher","unstructured":"Dykens EM, Maxwell MA, Pantino E et al Assessment of Hyperphagia in Prader-Willi Syndrome. https:\/\/doi.org\/10.1038\/oby.2007.216","DOI":"10.1038\/oby.2007.216"},{"key":"1743_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-48024-5","volume":"13","author":"L Matesevac","year":"2023","unstructured":"Matesevac L, Vrana-Diaz CJ, Bohonowych JE et al (2023) Analysis of hyperphagia questionnaire for clinical trials (HQ-CT) scores in typically developing individuals and those with Prader-Willi syndrome. Sci Rep 13:20573. https:\/\/doi.org\/10.1038\/s41598-023-48024-5","journal-title":"Sci Rep"},{"key":"1743_CR50","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.appet.2009.05.016","volume":"53","author":"MR Lowe","year":"2009","unstructured":"Lowe MR, Butryn ML, Didie ER et al (2009) The Power of Food Scale. A new measure of the psychological influence of the food environment. Appetite 53:114\u2013118. https:\/\/doi.org\/10.1016\/j.appet.2009.05.016","journal-title":"Appetite"},{"key":"1743_CR51","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1002\/oby.24216","volume":"33","author":"HE Diktas","year":"2025","unstructured":"Diktas HE, Cardel MI, Foster GD et al (2025) Development and validation of the Food Noise Questionnaire. Obes (Silver Spring) 33:289\u2013297. https:\/\/doi.org\/10.1002\/oby.24216","journal-title":"Obes (Silver Spring)"},{"key":"1743_CR52","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.862817","volume":"13","author":"O Abawi","year":"2022","unstructured":"Abawi O, Koster EC, Welling MS et al (2022) Resting energy expenditure and body composition in children and adolescents with genetic, hypothalamic, medication-induced or multifactorial severe obesity. Front Endocrinol (Lausanne) 13:862817. https:\/\/doi.org\/10.3389\/fendo.2022.862817","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1743_CR53","doi-asserted-by":"publisher","first-page":"5395","DOI":"10.1210\/jc.2010-0993","volume":"95","author":"H Holmer","year":"2010","unstructured":"Holmer H, Pozarek G, Wirf\u00e4lt E et al (2010) Reduced energy expenditure and impaired feeding-related signals but not high energy intake reinforces hypothalamic obesity in adults with childhood onset craniopharyngioma. J Clin Endocrinol Metab 95:5395\u20135402. https:\/\/doi.org\/10.1210\/jc.2010-0993","journal-title":"J Clin Endocrinol Metab"},{"key":"1743_CR54","doi-asserted-by":"publisher","first-page":"2588","DOI":"10.1210\/jc.2007-2672","volume":"93","author":"MG Shaikh","year":"2008","unstructured":"Shaikh MG, Grundy RG, Kirk JMW (2008) Reductions in basal metabolic rate and physical activity contribute to hypothalamic obesity. J Clin Endocrinol Metab 93:2588\u20132593. https:\/\/doi.org\/10.1210\/jc.2007-2672","journal-title":"J Clin Endocrinol Metab"},{"key":"1743_CR55","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1249\/01.MSS.0000078924.61453.FB","volume":"35","author":"CL Craig","year":"2003","unstructured":"Craig CL, Marshall AL, Sj\u00f6str\u00f6m M et al (2003) International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc 35:1381\u20131395. https:\/\/doi.org\/10.1249\/01.MSS.0000078924.61453.FB","journal-title":"Med Sci Sports Exerc"},{"key":"1743_CR56","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1093\/sleep\/14.6.540","volume":"14","author":"MW Johns","year":"1991","unstructured":"Johns MW (1991) A New Method for Measuring Daytime Sleepiness: The Epworth Sleepiness Scale. Sleep 14:540\u2013545. https:\/\/doi.org\/10.1093\/sleep\/14.6.540","journal-title":"Sleep"},{"key":"1743_CR57","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines13102356","volume":"13","author":"HL M\u00fcller","year":"2025","unstructured":"M\u00fcller HL (2025) Sleep disorders, dysregulation of circadian rhythms, and fatigue after craniopharyngioma\u2014a narrative review. Biomedicines 13:2356. https:\/\/doi.org\/10.3390\/biomedicines13102356","journal-title":"Biomedicines"},{"key":"1743_CR58","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1001\/archinte.166.10.1092","volume":"166","author":"RL Spitzer","year":"2006","unstructured":"Spitzer RL, Kroenke K, Williams JBW, L\u00f6we B (2006) A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med 166:1092\u20131097. https:\/\/doi.org\/10.1001\/archinte.166.10.1092","journal-title":"Arch Intern Med"},{"key":"1743_CR59","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","volume":"16","author":"K Kroenke","year":"2001","unstructured":"Kroenke K, Spitzer RL, Williams JB (2001) The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 16:606\u2013613. https:\/\/doi.org\/10.1046\/j.1525-1497.2001.016009606.x","journal-title":"J Gen Intern Med"},{"key":"1743_CR60","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/0165-1781(89)90047-4","volume":"28","author":"DJ Buysse","year":"1989","unstructured":"Buysse DJ, Reynolds CF, Monk TH et al (1989) The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 28:193\u2013213. https:\/\/doi.org\/10.1016\/0165-1781(89)90047-4","journal-title":"Psychiatry Res"},{"issue":"199511","key":"1743_CR61","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1002\/1097-4679","volume":"51","author":"JH Patton","year":"1995","unstructured":"Patton JH, Stanford MS, Barratt ES (1995) Factor structure of the Barratt impulsiveness scale. J Clin Psychol 51(199511):768\u2013774. https:\/\/doi.org\/10.1002\/1097-4679. )51:6%3C768::aid-jclp2270510607%3E3.0.co;2-1","journal-title":"J Clin Psychol"},{"key":"1743_CR62","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","volume":"30","author":"JE Ware","year":"1992","unstructured":"Ware JE, Sherbourne CD (1992) The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 30:473\u2013483","journal-title":"Med Care"},{"key":"1743_CR63","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1097\/00005650-200108000-00006","volume":"39","author":"JW Varni","year":"2001","unstructured":"Varni JW, Seid M, Kurtin PS (2001) PedsQL 4.0: reliability and validity of the Pediatric Quality of Life Inventory version 4.0 generic core scales in healthy and patient populations. Med Care 39:800\u2013812. https:\/\/doi.org\/10.1097\/00005650-200108000-00006","journal-title":"Med Care"},{"key":"1743_CR64","doi-asserted-by":"publisher","first-page":"972","DOI":"10.3390\/s26030972","volume":"26","author":"Y Hashimoto","year":"2026","unstructured":"Hashimoto Y (2026) A Comprehensive Review of Non-Invasive Core Body Temperature Measurement Techniques. Sens (Basel) 26:972. https:\/\/doi.org\/10.3390\/s26030972","journal-title":"Sens (Basel)"},{"key":"1743_CR65","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1159\/000487526","volume":"33","author":"M Bretault","year":"2018","unstructured":"Bretault M, Carette C, Barsamian C, Czernichow S (2018) Management of hypothalamic obesity during transition from childhood to adulthood. Endocr Dev 33:57\u201367. https:\/\/doi.org\/10.1159\/000487526","journal-title":"Endocr Dev"},{"key":"1743_CR66","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1007\/s11154-025-09972-7","volume":"26","author":"D De Alcubierre","year":"2025","unstructured":"De Alcubierre D, Feola T, Puliani G et al (2025) Endocrine and metabolic consequences of childhood-onset craniopharyngioma during the transition age: a literature review by the TALENT study group. Rev Endocr Metab Disord 26:989\u20131008. https:\/\/doi.org\/10.1007\/s11154-025-09972-7","journal-title":"Rev Endocr Metab Disord"},{"key":"1743_CR67","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2022-060640","volume":"151","author":"SE Hampl","year":"2023","unstructured":"Hampl SE, Hassink SG, Skinner AC et al (2023) Clinical practice guideline for the evaluation and treatment of children and adolescents with obesity. Pediatrics 151:e2022060640. https:\/\/doi.org\/10.1542\/peds.2022-060640","journal-title":"Pediatrics"},{"key":"1743_CR68","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1159\/000544880","volume":"18","author":"A Lecube","year":"2025","unstructured":"Lecube A, Azriel S, Barreiro E et al (2025) The Spanish GIRO guideline: a paradigm shift in the management of obesity in adults. Obes Facts 18:375\u2013387. https:\/\/doi.org\/10.1159\/000544880","journal-title":"Obes Facts"},{"key":"1743_CR69","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.1016\/j.clnu.2024.05.028","volume":"43","author":"IMAAV Roessel","year":"2024","unstructured":"Roessel IMAAV, Brink MVD, Dekker J et al (2024) Feasibility, safety, and efficacy of dietary or lifestyle interventions for hypothalamic obesity: A systematic review. Clin Nutr 43:1798\u20131811. https:\/\/doi.org\/10.1016\/j.clnu.2024.05.028","journal-title":"Clin Nutr"},{"key":"1743_CR70","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s00520-025-09361-5","volume":"33","author":"IMaA Van Roessel","year":"2025","unstructured":"Van Roessel IMaA, Van Schaik J, Kleinlugtenbelt LB et al (2025) Physical activity, health-related fitness, and physical performance in children with acquired hypothalamic dysfunction. Support Care Cancer 33:295. https:\/\/doi.org\/10.1007\/s00520-025-09361-5","journal-title":"Support Care Cancer"},{"key":"1743_CR71","doi-asserted-by":"publisher","first-page":"100177","DOI":"10.1016\/j.obpill.2025.100177","volume":"15","author":"IMa van Roessel","year":"2025","unstructured":"van Roessel IMa, de Koning A, Birk MJ MV, et al (2025) The introduction of a new mobile lifestyle tool in the battle against hypothalamic obesity; the HAPPYthalamus application. Obes Pillars 15:100177. https:\/\/doi.org\/10.1016\/j.obpill.2025.100177","journal-title":"Obes Pillars"},{"key":"1743_CR72","doi-asserted-by":"publisher","first-page":"2761","DOI":"10.1007\/s40618-025-02700-7","volume":"48","author":"D Tuccinardi","year":"2025","unstructured":"Tuccinardi D, Masi D, Watanabe M et al (2025) Precision obesity medicine: A phenotype-guided framework for pharmacologic therapy across the lifespan. J Endocrinol Invest 48:2761\u20132798. https:\/\/doi.org\/10.1007\/s40618-025-02700-7","journal-title":"J Endocrinol Invest"},{"key":"1743_CR73","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1159\/000509302","volume":"13","author":"J van Schaik","year":"2020","unstructured":"van Schaik J, Begijn DGA, van Iersel L et al (2020) Experiences with Glucagon-Like Peptide-1 Receptor Agonist in Children with Acquired Hypothalamic Obesity. Obes Facts 13:361\u2013370. https:\/\/doi.org\/10.1159\/000509302","journal-title":"Obes Facts"},{"key":"1743_CR74","doi-asserted-by":"publisher","DOI":"10.1210\/jendso\/bvae200","volume":"9","author":"P Dimitri","year":"2024","unstructured":"Dimitri P, Roth CL (2024) Treatment of hypothalamic obesity with GLP-1 analogs. J Endocr Soc 9:bvae200. https:\/\/doi.org\/10.1210\/jendso\/bvae200","journal-title":"J Endocr Soc"},{"key":"1743_CR75","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s11102-025-01564-7","volume":"28","author":"E Gjersdal","year":"2025","unstructured":"Gjersdal E, Klit F\u00d8, Schmidt Ettrup K et al (2025) Semaglutide treatment in hypothalamic obesity: Two-Year outcomes on body composition, appetite, and quality of life. Pituitary 28:93. https:\/\/doi.org\/10.1007\/s11102-025-01564-7","journal-title":"Pituitary"},{"key":"1743_CR76","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1159\/000495851","volume":"12","author":"C Denzer","year":"2019","unstructured":"Denzer C, Denzer F, Lennerz BS et al (2019) Treatment of Hypothalamic Obesity with Dextroamphetamine: A Case Series. Obes Facts 12:91\u2013102. https:\/\/doi.org\/10.1159\/000495851","journal-title":"Obes Facts"},{"key":"1743_CR77","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.845937","volume":"13","author":"J van Schaik","year":"2022","unstructured":"van Schaik J, Welling MS, de Groot CJ et al (2022) Dextroamphetamine treatment in children with hypothalamic obesity. Front Endocrinol (Lausanne) 13:845937. https:\/\/doi.org\/10.3389\/fendo.2022.845937","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1743_CR78","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/S2213-8587(24)00087-1","volume":"12","author":"CL Roth","year":"2024","unstructured":"Roth CL, Scimia C, Shoemaker AH et al (2024) Setmelanotide for the treatment of acquired hypothalamic obesity: a phase 2, open-label, multicentre trial. Lancet Diabetes Endocrinol 12:380\u2013389. https:\/\/doi.org\/10.1016\/S2213-8587(24)00087-1","journal-title":"Lancet Diabetes Endocrinol"},{"key":"1743_CR79","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1056\/NEJMoa2512275","volume":"395","author":"JL Miller","year":"2026","unstructured":"Miller JL, van Santen HM, Phillips SA et al (2026) Setmelanotide for the treatment of acquired hypothalamic obesity. N Engl J Med 395:138\u2013150. https:\/\/doi.org\/10.1056\/NEJMoa2512275","journal-title":"N Engl J Med"},{"key":"1743_CR80","unstructured":"Rhythm Pharmaceuticals Reports First Quarter (2026) 2026 Financial Results and Business Update \u2013 Rhythm Pharmaceuticals, Inc. https:\/\/ir.rhythmtx.com\/news-releases\/news-release-details\/rhythm-pharmaceuticals-reports-first-quarter-2026-financial\/. Accessed 11 May"},{"key":"1743_CR81","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s40265-025-02280-z","volume":"86","author":"CL Roth","year":"2026","unstructured":"Roth CL, Doelman-Oldenburger NJ, van Santen HM (2026) Current and future pharmacological interventions for acquired hypothalamic obesity. Drugs 86:411\u2013427. https:\/\/doi.org\/10.1007\/s40265-025-02280-z","journal-title":"Drugs"},{"key":"1743_CR82","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1007\/s11102-024-01429-5","volume":"27","author":"M Svendstrup","year":"2024","unstructured":"Svendstrup M, Rasmussen AK, Kistorp C et al (2024) Semaglutide treatment of hypothalamic obesity - a real-life data study. Pituitary 27:685\u2013692. https:\/\/doi.org\/10.1007\/s11102-024-01429-5","journal-title":"Pituitary"},{"key":"1743_CR83","doi-asserted-by":"publisher","first-page":"417949","DOI":"10.1155\/2011\/417949","volume":"2011","author":"JK Hamilton","year":"2011","unstructured":"Hamilton JK, Conwell LS, Syme C et al (2011) Hypothalamic Obesity following Craniopharyngioma Surgery: Results of a Pilot Trial of Combined Diazoxide and Metformin Therapy. Int J Pediatr Endocrinol 2011:417949. https:\/\/doi.org\/10.1155\/2011\/417949","journal-title":"Int J Pediatr Endocrinol"},{"key":"1743_CR84","doi-asserted-by":"publisher","first-page":"2586","DOI":"10.1210\/jc.2002-030003","volume":"88","author":"RH Lustig","year":"2003","unstructured":"Lustig RH, Hinds PS, Ringwald-Smith K et al (2003) Octreotide therapy of pediatric hypothalamic obesity: a double-blind, placebo-controlled trial. J Clin Endocrinol Metab 88:2586\u20132592. https:\/\/doi.org\/10.1210\/jc.2002-030003","journal-title":"J Clin Endocrinol Metab"},{"key":"1743_CR85","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1530\/EJE-21-0972","volume":"186","author":"K Huynh","year":"2022","unstructured":"Huynh K, Klose M, Krogsgaard K et al (2022) Randomized controlled trial of Tesomet for weight loss in hypothalamic obesity. Eur J Endocrinol 186:687\u2013700. https:\/\/doi.org\/10.1530\/EJE-21-0972","journal-title":"Eur J Endocrinol"},{"key":"1743_CR86","doi-asserted-by":"publisher","first-page":"3888","DOI":"10.1210\/jc.2016-2118","volume":"101","author":"M Fleseriu","year":"2016","unstructured":"Fleseriu M, Hashim IA, Karavitaki N et al (2016) Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 101:3888\u20133921. https:\/\/doi.org\/10.1210\/jc.2016-2118","journal-title":"J Clin Endocrinol Metab"},{"key":"1743_CR87","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.1210\/jc.2012-4184","volume":"98","author":"M Bretault","year":"2013","unstructured":"Bretault M, Boillot A, Muzard L et al (2013) Clinical review: Bariatric surgery following treatment for craniopharyngioma: a systematic review and individual-level data meta-analysis. J Clin Endocrinol Metab 98:2239\u20132246. https:\/\/doi.org\/10.1210\/jc.2012-4184","journal-title":"J Clin Endocrinol Metab"},{"key":"1743_CR88","doi-asserted-by":"publisher","first-page":"e426","DOI":"10.1210\/clinem\/dgab567","volume":"107","author":"HL M\u00fcller","year":"2022","unstructured":"M\u00fcller HL (2022) Bariatric Interventions in Craniopharyngioma Patients-Best Choice or Last Option for Treatment of Hypothalamic Obesity? J Clin Endocrinol Metab 107:e426\u2013e428. https:\/\/doi.org\/10.1210\/clinem\/dgab567","journal-title":"J Clin Endocrinol Metab"},{"key":"1743_CR89","doi-asserted-by":"publisher","first-page":"2321","DOI":"10.1007\/s11695-022-06079-9","volume":"32","author":"P Faucher","year":"2022","unstructured":"Faucher P, Carette C, Jannot A-S et al (2022) Five-Year Changes in Weight and Diabetes Status After Bariatric Surgery for Craniopharyngioma-Related Hypothalamic Obesity: a Case-Control Study. Obes Surg 32:2321\u20132331. https:\/\/doi.org\/10.1007\/s11695-022-06079-9","journal-title":"Obes Surg"},{"key":"1743_CR90","doi-asserted-by":"publisher","first-page":"2250","DOI":"10.1093\/neuonc\/noad112","volume":"25","author":"J Van Schaik","year":"2023","unstructured":"Van Schaik J, Schouten-van Meeteren AYN, Vos-Kerkhof E et al (2023) Treatment and outcome of the Dutch childhood craniopharyngioma cohort study: first results after centralization of care. Neuro Oncol 25:2250\u20132261. https:\/\/doi.org\/10.1093\/neuonc\/noad112","journal-title":"Neuro Oncol"},{"key":"1743_CR91","unstructured":"Rhythm Pharmaceuticals Announces Additional Positive Data from Phase 3 TRANSCEND trial of Setmelanotide in Patients with Acquired Hypothalamic Obesity \u2013 Rhythm Pharmaceuticals, Inc. https:\/\/ir.rhythmtx.com\/news-releases\/news-release-details\/rhythm-pharmaceuticals-announces-additional-positive-data-phase\/. Accessed 14 Apr 2026"}],"container-title":["Pituitary"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-026-01743-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11102-026-01743-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-026-01743-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T17:42:21Z","timestamp":1788457341000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11102-026-01743-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":91,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["1743"],"URL":"https:\/\/doi.org\/10.1007\/s11102-026-01743-0","relation":{},"ISSN":["1386-341X","1573-7403"],"issn-type":[{"value":"1386-341X","type":"print"},{"value":"1573-7403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"30 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"BB is on the editorial board of Pituitary. She was not involved in the review or editorial process for this paper, on which she is listed as an author. She has also participated in advisory boards for Rhythm Pharmaceuticals and Novo Nordisk.AC has participated in advisory boards for Palobiofarma SL and has served as a consultant or speaker for Rhythm Pharmaceuticals, Sandoz, and Novo Nordisk.MDOG has participated as a consultant or speaker for Novo Nordisk, Lilly, Sanofi, and Recordati.AL has served as a consultant and\/or speaker for Rhythm Pharmaceuticals, Novo Nordisk, Boehringer, and Lilly.MDBP has served as a consultant and\/or speaker for Lilly, Novo Nordisk, Pfizer, Abbott Nutrition, Fresenius Kabi, Nestl\u00e9 Health Science, Danone Nutricia, QoL, Nutrisens, and Persan Farma. All interactions were conducted in accordance with ethical industry standards, and the content of this work remains independent and unbiased.JJLG has participated as a consultant and\/or invited speaker for Lilly, Novo Nordisk, Abbott Nutrition, Nutrimed, Fresenius Kabi, Nestl\u00e9 Health Science, Danone Nutricia, QoLife, Nutrisens, and Persan Farma. All other authors declare that they have no known competing financial or personal interests that could have appeared to influence the work reported in this paper.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"138"}}